Showing results (421-430 of 757) with videos related to
Sort By:
Pageof 76
Heart (British Cardiac Society)|August 7, 2017
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.Kidney International|November 26, 2016
Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceVlado Perkovic, Rajiv Agarwal, Paola Fioretto, et al.Journal of the American Society of Nephrology : JASN|November 15, 2014
Contrasting Cholesterol Management Guidelines for Adults with CKDLisandro D Colantonio, Usman Baber, Maciej Banach, et al.Diabetes, Obesity & Metabolism|January 27, 2021
Impact of polyvascular disease with and without co-existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of EMPA-REG OUTCOMESubodh Verma, C David Mazer, Silvio E Inzucchi, et al.Journal of Medical Economics|July 13, 2023
Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetesPeter Rossing, Franziska Groehl, Paul Mernagh, et al.International Journal of Cardiology. Heart & Vasculature|July 16, 2019
Aortic stiffness is independently associated with interstitial myocardial fibrosis by native T1 and accelerated in the presence of chronic kidney diseaseMengzhen Chen, Luca Arcari, Juergen Engel, et al.The Journal of Pathology|June 10, 2014
Direct acute tubular damage contributes to Shigatoxin-mediated kidney failureStefan Porubsky, Giuseppina Federico, Johannes Müthing, et al.Kidney International Supplements|January 25, 2019
Renal replacement therapy for refugees with end-stage kidney disease: an international survey of the nephrological communityWim Van Biesen, Raymond Vanholder, Bert Vanderhaegen, et al.Journal of Diabetes and Its Complications|February 12, 2026
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITYRobert Weingold, Gerasimos Filippatos, Stefan D Anker, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2026
Impact of SGLT2 inhibitors in patients with Fabry diseaseMalte Lenders, Sima Canaan-Kühl, Christine Kurschat, et al.Pageof 76